Partner Therapeutics Inc

FDA Regulatory Profile

Partner Therapeutics Inc appears in FDA public data with 1 recall, 0 510(k) clearances, 8 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0655-2021, Class III) was initiated on June 23, 2021.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
8
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0655-2021Class IIILEUKINE (Sargramostim) for Injection, 250 mcg/ vial, 5mL vials, 5 (250 mcg vials) per box, Rx only, June 23, 2021